Ketanest

Esketamine, the active ingredient in Ketanest, is a NMDA receptor antagonist presented as a sterile injectable solution for intramuscular and intravenous use. It provides rapid dissociative anesthesia and analgesia for patients undergoing surgical procedures or requiring procedural sedation.

GNH USA supplies Ketanest as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Clients benefit from comprehensive regulatory support and consistent product availability across multiple markets.

Esketamine is used in anesthesia to achieve rapid dissociative sedation through NMDA receptor blockade.

Induction of general anesthesia: Provides rapid onset of dissociative anesthesia for surgical procedures. Procedural sedation: Allows controlled sedation for short diagnostic or therapeutic interventions. Adjunct analgesia: Enhances pain control during operative procedures when combined with other anesthetics.

Esketamine may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: transient feeling of light‑headedness. - Nausea or vomiting: gastrointestinal upset that may require anti‑emetic therapy. - Increased blood pressure: transient hypertension observed during induction. - Visual disturbances: altered perception or blurred vision.

Serious or Rare Side Effects: - Respiratory depression: reduced breathing effort requiring airway support. - Emergence delirium: severe agitation or confusion on recovery. - Cardiac arrhythmia: irregular heart rhythm that may need monitoring and intervention.

When using Ketanest, clinicians should observe specific safety measures to minimize risk.

Cardiovascular monitoring: Observe for hypertension and tachycardia during administration. Respiratory support: Be prepared to manage potential respiratory depression. Psychiatric assessment: Avoid use in patients with uncontrolled psychosis or severe anxiety. Drug interactions: Review concomitant CNS depressants and sympathomimetic agents. Store at ambient temperature below 25°C: Keep in original container, protect from moisture and light.

Esketamine can interact with several medication classes; awareness of these interactions helps ensure safe use.

Major Interactions (Avoid): - Concurrent use with other NMDA antagonists: May potentiate anesthetic effects and respiratory depression. - MAO inhibitors: Increased risk of hypertensive crisis.

Moderate Interactions (Monitor Closely): - Benzodiazepines: May enhance sedation, requiring dose adjustment. - Sympathomimetic agents (e.g., epinephrine): May exacerbate hypertension. - Alcohol: Additive central nervous system depression.